Nordic Medical Solutions Scandinavia ApS — Credit Rating and Financial Key Figures
CVR number: 40641246
Axeltorv 2 F, 1609 København V
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 4 389.54 | 15 647.56 | 12 208.07 | 5 186.21 | 1 805.69 |
| Employee benefit expenses | -2 383.50 | -4 390.63 | -3 821.65 | -3 691.87 | -1 134.20 |
| Total depreciation | -29.91 | ||||
| EBIT | 2 006.04 | 11 256.92 | 8 386.41 | 1 494.34 | 641.58 |
| Other financial income | 3.02 | 111.48 | 0.30 | 25.05 | 49.87 |
| Other financial expenses | - 167.17 | -14.30 | - 552.56 | - 650.47 | -9.09 |
| Pre-tax profit | 1 841.89 | 11 354.10 | 7 834.15 | 868.91 | 682.36 |
| Income taxes | - 437.11 | -2 526.16 | -1 760.25 | - 217.97 | - 173.25 |
| Net earnings | 1 404.78 | 8 827.94 | 6 073.90 | 650.94 | 509.11 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 302.27 | ||||
| Intangible rights | 272.36 | ||||
| Intangible assets total | 302.27 | 272.36 | |||
| Advance payments and construction in progress | 220.22 | 279.57 | |||
| Tangible assets total | 220.22 | 279.57 | |||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 770.37 | 1 784.38 | 1 747.38 | 1 187.16 | 5 281.21 |
| Advance payments | 1 685.77 | 1 585.56 | 460.96 | 2 695.97 | |
| Inventories total | 2 456.14 | 3 369.94 | 2 208.34 | 1 187.16 | 7 977.17 |
| Current trade debtors | 3 941.61 | 5 464.20 | 3 862.33 | 3 383.17 | 2 874.07 |
| Current amounts owed by group member comp. | 131.02 | 138.80 | 877.48 | 1 307.34 | |
| Prepayments and accrued income | 2.86 | 62.64 | 72.05 | 61.62 | |
| Current other receivables | 385.89 | 26.55 | 1.46 | ||
| Short term receivables total | 4 461.38 | 5 629.55 | 3 924.97 | 4 332.69 | 4 244.49 |
| Cash and bank deposits | 29.41 | 5 987.08 | 7 034.48 | 862.11 | 557.08 |
| Cash and cash equivalents | 29.41 | 5 987.08 | 7 034.48 | 862.11 | 557.08 |
| Balance sheet total (assets) | 6 946.93 | 15 206.80 | 13 447.36 | 6 684.23 | 13 051.10 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Shares repurchased | 7 827.94 | 5 323.90 | 2 855.72 | 509.11 | |
| Retained earnings | -6 423.16 | -2 919.12 | 299.06 | 440.89 | |
| Profit of the financial year | 1 404.78 | 8 827.94 | 6 073.90 | 650.94 | 509.11 |
| Shareholders equity total | 1 454.78 | 10 282.73 | 8 528.68 | 3 855.72 | 1 509.11 |
| Provisions | 15.85 | 73.48 | |||
| Non-current other liabilities | 33.66 | ||||
| Non-current deferred tax liabilities | 437.11 | 2 526.16 | 1 760.25 | 202.12 | 115.62 |
| Non-current liabilities total | 437.11 | 2 559.82 | 1 760.25 | 202.12 | 115.62 |
| Current loans from credit institutions | 65.11 | 115.80 | 196.73 | 20.35 | 26.71 |
| Advances received | 6.71 | 13.74 | 50.03 | 17.06 | 582.64 |
| Current trade creditors | 240.31 | 485.83 | 1 556.58 | 1 245.78 | 800.87 |
| Current owed to group member | 4 211.66 | 23.84 | 237.19 | 496.05 | 9 468.22 |
| Short-term deferred tax liabilities | 54.00 | ||||
| Other non-interest bearing current liabilities | 531.25 | 1 725.04 | 1 117.90 | 777.28 | 474.45 |
| Current liabilities total | 5 055.04 | 2 364.25 | 3 158.43 | 2 610.53 | 11 352.89 |
| Balance sheet total (liabilities) | 6 946.93 | 15 206.80 | 13 447.36 | 6 684.23 | 13 051.10 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.